1. Bieche, I, Parfait, B, Le Doussal, V, Lidereau, R, Vidaud, M. . Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. In Cancer research, 61, 1652-8. doi:. https://pubmed.ncbi.nlm.nih.gov/11245479/
2. Lohmann, D R. . RB1 gene mutations in retinoblastoma. In Human mutation, 14, 283-8. doi:. https://pubmed.ncbi.nlm.nih.gov/10502774/
3. Jamalvandi, Mina, Motovali-Bashi, Majid, Amirmahani, Farzane, Darvishi, Parisa, Jamshidi Goharrizi, Kiarash. 2018. Association of T/A polymorphism in miR-1302 binding site in CGA gene with male infertility in Isfahan population. In Molecular biology reports, 45, 413-417. doi:10.1007/s11033-018-4176-x. https://pubmed.ncbi.nlm.nih.gov/29627965/
4. Rudnizky, Sergei, Malik, Omri, Bavly, Adaiah, Melamed, Philippa, Kaplan, Ariel. 2017. Nucleosome mobility and the regulation of gene expression: Insights from single-molecule studies. In Protein science : a publication of the Protein Society, 26, 1266-1277. doi:10.1002/pro.3159. https://pubmed.ncbi.nlm.nih.gov/28329910/
5. Bièche, I, Parfait, B, Noguès, C, Lidereau, R, Vidaud, M. . The CGA gene as new predictor of the response to endocrine therapy in ER alpha-positive postmenopausal breast cancer patients. In Oncogene, 20, 6955-9. doi:. https://pubmed.ncbi.nlm.nih.gov/11687975/
6. Cowell, J K, Smith, T, Bia, B. . Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. In European journal of human genetics : EJHG, 2, 281-90. doi:. https://pubmed.ncbi.nlm.nih.gov/7704558/
智鼠故事 
